Astex Pharmaceuticals to Participate on Oncology Panels at Upcoming Investor Conferences

9/18/2012 6:00 AM EST

Astex Pharmaceuticals, Inc.
Press release

Astex Pharmaceuticals to Participate on Oncology Panels at Upcoming Investor
Conferences

DUBLIN, Calif., 2012-09-18 12:00 CEST (GLOBE NEWSWIRE) -- Astex
Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the
discovery and development of novel small molecule therapeutics, today announced
that members of the Astex management team will participate as presenters on
oncology panels at two upcoming investor conferences. 

Michael V. McCullar, PhD, MBA, senior vice president, business development,
will take part in a panel discussion titled, "Targeted Oncology - Changing
Cancer Therapy, Again" on Monday, September 24th at 1:00 pm ET at the Noble
Financial Capital Markets Life Sciences Exposition in Stamford, Connecticut. 

The following week, Harren Jhoti, PhD, president and director, will participate
on a panel titled "Oncology Business Models" on Monday, October 1st at 3:15 pm
CET at the Sachs Associates Biotech in Europe Investor Forum in Zurich,
Switzerland. Just prior to the panel, Dr. Jhoti will deliver the Astex
Pharmaceuticals corporate presentation for Forum attendees at 12 noon CET. 

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel
small molecule therapeutics with a focus on oncology. The Company is developing
a proprietary pipeline of novel therapies and is creating de-risked products
for partnership with leading pharmaceutical companies. Astex Pharmaceuticals
developed Dacogen® (decitabine) for Injection and receives significant
royalties on global sales. 

For more information about Astex Pharmaceuticals, Inc., please visit
http://www.astx.com. 

The Astex Pharmaceuticals, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=12273 


         CONTACT: Timothy L. Enns
         Astex Pharmaceuticals, Inc.
         Senior Vice President
         Corporate Communications & Marketing
         Tel: +1 (925) 560-2810
         E-mail:  
         
         Susanna Chau
         Astex Pharmaceuticals, Inc.
         Manager
         Investor Relations
         Tel: +1 (925) 560-2845
         E-mail:  
         
         Alan Roemer
         The Trout Group
         Managing Director
         Tel: +1 (646) 378-2945
         E-mail:  
         
         Kari Watson
         MacDougall Biomedical Communications
         Senior Vice President
         Tel: +1 (781) 235-3060
         E-mail: